1. Potassium channel-related genes are a novel prognostic signature for the tumor microenvironment of renal clear cell carcinoma
   Rui Zeng et al, 2022, Frontiers in Oncology CrossRef
2. Inquiring into the collusion between two-system diseases: Potential impact of hypertension over gastroesophageal reflux disease
   Arícia G. Miranda et al, 2024, Medical Hypotheses CrossRef
3. Metabolism-inflammasome crosstalk shapes innate and adaptive immunity
   Jun Wu et al, 2024, Cell Chemical Biology CrossRef
4. Ion Channels and Transporters in Inflammation: Special Focus on TRP Channels and TRPC6
   Giuseppe Ramirez et al, 2018, Cells CrossRef
5. Metalloimmunology: The metal ion-controlled immunity
   Chenguang Wang et al, 2020, Advances in Immunology in China - Part B CrossRef
6. The NLRP3 Inflammasome in the Pathogenesis and Treatment of Alzheimer’s Disease
   Mahdieh Golzari-Sorkheh et al, 2021, Journal of Alzheimer's Disease CrossRef
7. NXC736 Attenuates Radiation-Induced Lung Fibrosis via Regulating NLRP3/IL-1β Signaling Pathway
   Sang Yeon Kim et al, 2023, International Journal of Molecular Sciences CrossRef
8. The role of NLRP3 inflammasome in aging and age-related diseases
   Ruikai Liang et al, 2024, Immunity & Ageing CrossRef
9. Ion homeostasis and ion channels in NLRP3 inflammasome activation and regulation
   Iva Hafner-Bratkovič et al, 2018, Current Opinion in Immunology CrossRef
10. The renal immune-inflammatory component of arterial hypertension: emerging therapeutic strategies
    Nuria Garcia-Fernandez et al, 2019, Cardiovascular Research CrossRef
11. COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches
    F. Moccia et al, 2020, GeroScience CrossRef
12. NLRP3 inflammasome in cardiovascular diseases: Pathophysiological and pharmacological implications
    Carolina Pellegrini et al, 2021, Medicinal Research Reviews CrossRef
13. The potential convergence of NLRP3 inflammasome, potassium, and dopamine mechanisms in Parkinson’s disease
    Adrianne F. Pike et al, 2022, npj Parkinson's Disease CrossRef
14. The Kv1.3 channel-inhibitory toxin BF9 also displays anticoagulant activity via inhibition of factor XIa
    Li Ding et al, 2018, Toxicon CrossRef
15. Synergistic effects of electronegative-LDL- and palmitic-acid-triggered IL-1β production in macrophages via LOX-1- and voltage-gated-potassium-channel-dependent pathways
    Po-Yuan Chang et al, 2021, The Journal of Nutritional Biochemistry CrossRef
16. Calcium-sensing receptor-mediated macrophage polarization improves myocardial remodeling in spontaneously hypertensive rats
    Jiaqi Zhao et al, 2024, Experimental Biology and Medicine CrossRef
17. ENaC-mediated sodium influx exacerbates NLRP3-dependent inflammation in cystic fibrosis
    Thomas Scambler et al, 2019, eLife CrossRef
18. Emerging Role of the Inflammasome and Pyroptosis in Hypertension
    Carmen De Miguel et al, 2021, International Journal of Molecular Sciences CrossRef
19. Insights into inflammasome regulation: cellular, molecular, and pathogenic control of inflammasome activation
    Naveen Challagundla et al, 2022, Immunologic Research CrossRef
20. Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets
    Vaidya Govindarajan et al, 2020, Journal of Neuroinflammation CrossRef
21. PAP-1 ameliorates DSS-induced colitis with involvement of NLRP3 inflammasome pathway
    Yongyu Mei et al, 2019, International Immunopharmacology CrossRef
22. Kv1.3 channel blockade alleviates cerebral ischemia/reperfusion injury by reshaping M1/M2 phenotypes and compromising the activation of NLRP3 inflammasome in microglia
    Dai-Chao Ma et al, 2020, Experimental Neurology CrossRef
23. Role of Skin Stretch on Local Vascular Permeability in Murine and Cell Culture Models
    Tuna Demir et al, 2022, Plastic and Reconstructive Surgery - Global Open CrossRef
24. Role of pyroptosis in cardiovascular disease
    Zeng Zhaolin et al, 2019, Cell Proliferation CrossRef
25. Pyroptosis-Related Inflammasome Pathway: A New Therapeutic Target for Diabetic Cardiomyopathy
    Zhengyao Cai et al, 2022, Frontiers in Pharmacology CrossRef